össur annual report2009 - Euroland
össur annual report2009 - Euroland
össur annual report2009 - Euroland
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Amortization classified by operational category, is shown in the following schedule:<br />
2009 2008<br />
Cost of goods sold 8 70<br />
Sales and marketing expenses 6,765 9,096<br />
Research and development expenses 3,441 4,185<br />
General and administrative expenses 354 1,404<br />
10,568 14,755<br />
Part of the intangible assets included above have finite useful lives, over which the assets are amortized.<br />
These intangible assets will be amortized on a straight line basis over their useful lives.<br />
The following useful lives are used in the calculation of amortisation.<br />
Customer and distribution relationships 4 - 5 years<br />
Patents 5 - 50 years<br />
Trademarks 3 - infinitive<br />
Other 3 - 10 years<br />
The Company main intangible assets are in relation to the acquisition of Royce Medical and<br />
Gibaud Group.The amortization in 2009 amounted to USD 10.5 million (2008: 14.8 million) and<br />
the expected amount for 2010 is USD 5.2 million. The Gibaud trademarks amounting to USD 16.1<br />
million are estimated to have infinitive life. The trademark has been well established within the<br />
French market since the foundation of the company in 1890.<br />
All amounts in thousands of USD 85 <strong>annual</strong> report 09<br />
Össur hf. consolidated financial stateMents 2009